Mechanism Of Action And Safety Of Seltorexant As A Monotherapy For Patients With Major Depressive Disorder: A Multicenter, Placebo-Controlled, Randomized, Double-Blind, Phase 1 Study
NEUROPSYCHOPHARMACOLOGY（2020）
关键词
Major Depressive Disorder (MDD), Orexin Receptor Antagonist, Seltorexant, Clinical Trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要